Key points from article :
A French startup called Bioptimus has raised $35 million to develop an AI "foundation model" that could unlock a deeper understanding of biological systems.
This AI model would analyse a vast amount of biological data, from the molecular level up to whole organisms, potentially offering insights into complex processes like aging.
The company was founded by Professor Jean-Philippe Vert, who has expertise from both Google DeepMind and the French company Owkin.
Owkin's resources, including patient data from hospitals around the world, will be crucial in training Bioptimus's powerful AI model.
Investors, including Sofinnova Partners and Bpifrance Large Venture, believe this AI model has the potential to revolutionise how we understand and personalise medicine.
